M&A deals, company strategies, pipeline updates and more
Follow our coverage of the 2019 J.P. Morgan Healthcare Conference in San Francisco
NIIMBL is awarding $32 million in grants for a varied list of projects for improving biologics manufacturing, including for CAR-T drugs.
Pfizer has formed a partnership to manufacture some of its drugs in the rapidly growing Asian market.
With the government shutdown now in its fourth week, FDA Commissioner Scott Gottlieb says about 260 medical product inspectors have been recalled.
The American Hospital Association has crafted a lengthy list of suggestions for addressing drug shortages that include both the carrot and the stick.
Pfizer is offering some 1,700 door-heading employees "an attractive financial scheme that is significantly higher than the legal requirements."
AstraZeneca said the move is meant to "consolidate the biologics manufacturing network" at one large site in Maryland.
Eli Lilly says it's cutting 250 positions in France through a "voluntary exit plan" as it "modernizes" a Fegersheim plant.
FDA slaps Akorn with warning letter following an inspection of its sterile injectables plant in Illinois.
Here are some other manufacturing news stories we're following.
Mylan shelled out $9.4 million for Ascendis Health’s South African manufacturing plant that is focused on producing antiretrovirals to combat HIV.